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CARACTERÍSTICAS CLÍNICAS E PSICOSSOCIAIS DO PACIENTE COM INSUFICIÊNCIA
CARDÍACA QUE INTERNA POR DESCOMPENSAÇÃO CLÍNICA
CARACTERÍSTICAS CLÍNICAS Y PSICOSOCIALES DEL PACIENTE CON INSUFICIENCIA
CARDIACA INGRESADO EN HOSPITAL POR DESCOMPENSACIÓN CLÍNICA
RESUMO
Este estudo teve como objetivo identificar
perfil sociodemográfico e clínico, história
de hospitalizações por Insuficiência Cardí-
aca (IC) e seguimento (consultas regulares,
tratamento medicamentoso, fatores facili-
tadores e dificultadores do seguimento) do
paciente internado por quadro de descom-
pensação clínica. Foram entrevistados 61
pacientes com idade média de 58,1 (± 15,9)
anos, 3,5 (± 4,4) anos de estudo e renda
individual de 1,3 (± 2,4) salários-mínimos.
A maioria dos sujeitos se encontrava em
classe funcional III ou IV da New York Heart
Association, tendo como causa mais fre-
qüente de hospitalização, os sinais/sinto-
mas da forma congestiva da IC. 75,4% dos
sujeitos relataram acompanhamento clíni-
co, porém de periodicidade irregular. Cons-
tatou-se utilização de terapêutica medica-
mentosa em proporção inferior à recomen-
dada pela literatura. Os achados devem au-
xiliar a identificação dos pacientes com
maior risco de descompensação da IC e as-
sim, desenhar e implementar intervenções
específicas visando a redução das re-hos-
pitalizações por IC.
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ABSTRACT
This study had the purpose to identify the
sociodemographic and clinical profiles, his-
tory of hospitalizations due to Heart Fail-
ure (HF) and follow-ups (regular appoint-
ments, drug treatment, facilities and diffi-
culties for follow-up) of patients admitted
for clinical decompensation. Interviews
were held with 61 patients, with average
age of 58.1 (± 15.9) years, 3.5 (± 4.4) years
of education and individual income of 1.3
(± 2.4) times the minimum wage. Most sub-
jects were in functional classes III or IV of
the New York Heart Association, having
signs and symptoms of the congestive form
of HF as the most frequent cause of hospi-
talization. Of all subjects, 75.4% reported
clinical follow-ups, although they tended to
be irregular. The use of drug therapy oc-
curred in lower ratios than that recom-
mended in the literature. The findings must
help to identify patients with higher risk of
HC decompensation, and, as such, design
and implement specific interventions aim-
ing at reducing re-admittances due to HF.
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RESUMEN
Este estudio tuvo como objetivo identificar
el perfil sociodemográfico y clínico, la his-
toria de hospitalizaciones por Insuficiencia
Cardiaca (IC) y el seguimiento (consultas
regulares, tratamiento medicamentoso, y,
los factores facilitadores y dificultadores del
seguimiento) del paciente internado por
cuadro de descompensación clínica. Fueron
entrevistados 61 pacientes con edad pro-
medio de 58,1(±15,9) años, 3,5 (±4,4) años
de estudio y renta individual de 1,3 (±2,4)
salarios mínimos. La mayoría de los sujetos
se encontraba en la clase funcional III o IV
de la New York Heart Asociation, teniendo
como causa más frecuente de hospitaliza-
ción las señales/síntomas de la forma con-
gestiva de la IC; 75,4% de los sujetos rela-
taron acompañamiento clínico, sin embar-
go este era de una periodicidad irregular.
Se constató la utilización de terapéutica
medicamentosa en proporción inferior a la
recomendada por la literatura. Lo encon-
trado debe auxiliar a identificar los pacien-
tes con mayor riesgo de descompen-sación
de la IC, y así, proyectar e imple-mentar in-
tervenciones específicas que tengan como
objetivo la reducción de las hospitalizacio-
nes por IC.
DESCRIPTORES
Insuficiencia cardíaca.
Atención de enfermería.
Hospitalización.
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INTRODUCTION
Nowadays, there is a growing number of people afflicted
by heart failure (HF). In the United States, one in every three
Americans presented a cardiovascular disease, totaling
84,700,000 subjects from 1999 to 2004, five million of these
afflicted by HF. After age 65, the incidence of HF approaches
10 cases in every 1000 individuals(1). In spite of advances in
treatment, 300,000 patients die every year(2). In Brazil, there
are no epidemiological studies involving the incidence of
HF. However, according to other countries, it is estimated
that up to 6.4 million Brazilians suffer from HF. According
to data from the SUS (Single Health System - Sistema Único
de Saúde) and the Ministry of Health, in the year 2000,
approximately 398,000 hospitalizations occurred due to HF,
with the occurrence of 26,000 deaths. Nearly one third of
hospitalized SUS patients with heart diseases have HF(3).
One of the greatest problems related to HF evolution
regards the high rates of re-hospitalization(4-6) caused by
clinical decompensation. Besides resulting in high costs,
these are related to worsening ventricular functions. Stud-
ies have shown that each clinical decompensation event
results in additional aggravations to the myo-
cardium due to HF remodeling, resulting in a
functional degradation of the ventricle and
worsening clinical situation(6).
In Brazil, according to the SUS(7), approxi-
mately 400,000 hospitalizations with a HF
diagnosis occurred per year in 1998-2000. The
analysis of the period from January 1995 to
June 2002 points to a crescent number of
cases after the second decade of life, with the
numbers increasing twofold from the third to
fifth decade, even to the point of growing in the seventh
decade, with 466,093 hospitalizations in the period(7).
Re-hospitalizations would be related, firstly, to the ex-
istence of flaws in the hospital system itself, and, secondly,
to behavioral factors(8). The following behavioral factors can
be mentioned: inadequate compliance with medication,
difficulties to modify lifestyle and delays in seeking medical
care when the clinical situation worsens(9). Studies have
shown that functional worsening of the NYHA class and the
lack of planned follow-ups after the IC diagnosis(10), as well
as compromised quality of life (QL)(11) predict re-hospital-
izations within 30 and 60 days, respectively.
Therefore, factors that are external to the patient and
that contribute to decompensate their clinical situation
would include the lack of: documentation of the left ven-
tricular function, continuity of patient monitoring after
hospital discharge, successful stabilization of body weight,
adequate system for early detection of patients with signs
of worsening clinical situations, social support, healthcare
education, as well as the incapacity of services to identify
individual risks for re-hospitalizations due to non-compli-
ance with the treatment.
Literature notes that half of all hospitalizations could
be prevented by continuous clinical monitoring and
healthcare education of patients, promoting treatment
compliance(9).
The development and implementation of efficient strat-
egies requires the identification of the particular
sociodemographic and clinical profile of patients admitted
because of clinical decompensation, which may vary ac-
cording to region, local socio-cultural characteristics and
the availability of healthcare services.
Acting upon the factors related to clinical decompensa-
tion requires the work of a multidisciplinary team, due to
the complexity of HF patients. The nurse, as a member of
the multidisciplinary team, has the role of educator, which
requires a precise diagnosis of the magnitude of the fac-
tors related to the re-hospitalization problem and its de-
termining factors in order to better implement the educa-
tional strategies.
One of the largest teaching hospitals in the state of São
Paulo registers a significant number of HF hospitalizations
per year, but does not have data about the profile of the
patients  hospitalized due to clinical decom-
pensation. Therefore, the objective of this
study was to identify the sociodemographic
and clinical profile, the history of HF hospi-
talization and outpatient monitoring (regu-
lar appointments, drug treatment, facilitating
and hindering factors of the treatment) in
patients hospitalized with decompensated HF
in a teaching hospital in the State of São
Paulo.
The data contained in this study should
provide support to direct the clinical-educational activities
of nurses towards HF patients, aiming to minimize situa-
tions of clinical decompensation and their consequent re-
hospitalizations.
METHOD
Study type
This is a descriptive, exploratory study.
Subjects
Subjects were patients of both genders, admitted due
to HF decompensation, in the first 48 hours of hospitaliza-
tion. Patients who were unable to effectively communicate
verbally (due to neurological or psychiatric alterations) and
had HF but were hospitalized because of other reasons that
were not related to the decompensation were excluded.
Sample size (n=61) was limited by the data collection pe-
riod, which lasted from October, 2002 to August, 2003. The
subjects were selected for the study successively, accord-
Half of all
hospitalizations could
be prevented by
continuous clinical
monitoring and
healthcare education
of patients.
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ing to the hospitalization date, provided that they did not
present any exclusion criteria.
Data Collection
Data were collected in five inpatient units of a teaching
hospital in the city of Campinas – SP, where decompensated
HF hospitalizations are distributed. The following methods
were employed: 1. self-report: individual semi-structured
interviews, performed by any of the researchers. 2. bio-
physiological assessment: physical examination focused on
the identification of the main signs and symptoms related
to HF, performed by the same researcher after standard-
ization of techniques for its execution and assessment of
the results. 3. data available on records: consultations to
the hospital records archive.
Data collection instrument
The data collection instrument was specifically built for
this study and submitted to content validation by three
judges with expertise in cardiology and/or experience in
the clinical approach of patients with HF. The instrument
was divided in four sections: 1.) Sociodemographic charac-
terization – name, age, gender, hometown, education,
marital status, people the patient lives with, occupation,
individual and family income; 2.) Interview – held in order
to obtain the history of hospitalizations due to HF decom-
pensation, information about clinical follow-up, attending
pre-scheduled appointments and drug therapy used before
the current hospitalization, and associated clinical condi-
tions; 3.) Medical record checking, to obtain information
such as etiology and functional classification of the HF be-
fore and after the current hospitalization (prescribed dur-
ing the current hospitalization); 4.) Physical examination –
to identify the signs and symptoms of HF decompensation
due to the hospitalization and on the day of the interview.
The pre-test with five patients with decompensated HF con-
tributed to the final version of the instrument.
Left ventricular hypertrophy (LVH) was assessed based
on ecodopplercardiogram data, with the criteria for LVH
presence being at least one of the findings: thickness of
the myocardial septum or posterior wall of the left ven-
tricle higher or equal to 11 mm, and ventricular mass of
259g for men and 166g for women(12).
Analysis of the results:
Data were submitted to descriptive statistical analysis,
followed by associative tests with Fisher’s exact test or chi-
square test for categorical variables, and Mann-Whitney’s
test to compare continuous variables.
The study was approved by the Review Board of
Faculdade de Ciências Médicas da UNICAMP (file CEP #233/
2002). All selected patients signed the consent form.
RESULTS
The 61-patient group had a slight predominance of
males (54.1%); average age was 58.1 (±15.8) years and 3.5
(±4.4) years of education. Most subjects had a stable part-
ner (60.6%), 34.4% lived with a spouse or children, 54.1%
had no job, with a reported monthly income of 1.36 (±2.4)
times the minimum wage (MW) (Table 1).
Only 29.5% (18/61) of the patients had HF hospital records
of functional classification (FC) in accordance with NYHA
before hospitalization. These 18 patients had been classified
in the last clinical evaluation, previous to the hospitalization,
such as: FC I: 5.5%; FC II 16.6%; FC III 50.0%; FC IV 27.8%. At
the hospitalization, almost all patients (91.8%) were in FC IV.
Among the associated clinical conditions, systemic hy-
pertension (SH) (57.4%; 35/61), heart valve diseases, kid-
ney failure and coronary diseases were frequent, present
in similar proportions (31%; 19/61).
Regarding the signs and symptoms resulting from HF,
as recorded on the day of hospitalization, the following signs
are worth noting: lower limb edema (80.3%), fine rales
(75.4%) and hepatomegaly (55.7%). Regarding symptoms,
dyspnea (85.2%) stands out (Table 2).
Regarding the signs and symptoms investigated actively
by the researcher, the most prevalent symptom was dysp-
nea (96.7%), followed by fatigue (93.4%), coughing and
palpitation, present in equal amounts (46.6%). As for the
signs, the fine rales (85.2%) and lower limb edemas (82.0%)
were noted (Table 2). The distribution analysis of the signs
and symptoms among males and females showed a signifi-
cantly higher frequency of coughing (p=0.0325 c2) and head-
aches (p=0.0141c2) among women.
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Table 1 - Sociodemographic and clinical characterization of the 61 studied patients with decompensated HF - Campinas - 2002-2003
Variable N (%)
Average
( ± dp)*
Median Variation
Age (years) 58.1 (± 15.9) 60.0 20- 92
Gender
Male 33 (54.1)
Female 28 (45.9)
Education (years) 3.5 (± 4.4)
2.0 0 - 21
Marital Status
Married 32 (52.4)
Widowed 12 (19.7)
Single 8 (13.1)
Stable union 5 (8.2)
Other 4 (6.6)
Family composition
Lives alone 4 (6.6)
With the family/partner/children 57 (93.4)
Occupation
Active 10 (16.4)
Inactive 33 (54.1)
Housewife 18 (29.4)
Monthly individual income (MW)** 1.2 (±1.2) 1.0 0 - 16.7
Monthly family income (MW) 2.4 (±1.6) 2.0 0.8 - 8.5
Hometown
City of Campinas 30 (49.2)
Campinas neighboring towns 19 (31.1)
Other cities in the state of São Paulo 12 (19.7)
Functional Class at hospitalization
Class III 5 (8.2)
Class IV 56 (91.8)
Associated clinical conditions
SH 35 (57.4)
Smoking 31 (50.8)
Coronary disease 19 (31.1)
Heart valve disease 19 (31.1)
Diabetes mellitus 18 (29.5)
Kidney failure 18 (29.5)
Emphysema/asthma/bronchitis 16 (26.2)
Chagas Disease 9 (14.7)
Dyslipidemia 6 (9.8)
*dp = desvio-padrão
**SM = salário mínimo
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Table 2 – Signs and symptoms related to HF identified in the hospital records at the moment of hospitalization and during the physical
exam on the day of the interview – Campinas - 2002-2003
Data obtained from the
medical record on the
day of hospitalization
Total
N %
SYMPTOMS
Dyspnea
Coughing
Precordial pain
Fatigue
Dizziness
Palpitation
Headache
52 85.2
21 34.4
08 13.1
04 6.5
03 5.0
05 8.3
- -
SIGNS
Edema 49 80.3
Fine rales 46 75.4
Hepatomegaly 34 55.7
Ascites 26 42.6
Jugular Stasis 15 24.6
Third heart sound 03 4.9
HR average (±sd) (bpm )++ 82.7 ( ± 20.2) --
RF· ··average (±dp) (mpm) 23.2 ( ± 6.7) --
SBP average (±sd) (mmHg)▪ 124.9 ( ± 35.2) --
DBP average (±dp) (mmHg) 77.0 ( ± 16.9) --
Total
N %
59 96.7
28 46.6
17 27.8
57 93.4
17 28.3
28 46.6
15 24.6
50 81.9
52 85.2
3 6 59.0
41 67.2
41 67.2
-- --
82.9 ( ± 16.0) --
22.7 ( ± 4.1) --
116.5 ( ± 21.6) --
75.7 ( ± 11.4) --
+
▪▪
Data obtained from the physical
examination, performed on the
day of the interview.
+heart rate, ++beats per minute, • respiratory frequency, • • movements per minute,
?systolic blood pressure, ??diastolic blood pressure, ## p-value = 0,0166.
Evidence of structural heart injuries, identified with
ecodopplercardiograms, was investigated in 32 patients
who performed the exam during hospitalization. The sys-
tolic and diastolic diameters of the left ventricle were ob-
served, as well as the left atrium diameter, itself an evi-
dence of structural heart injury, and still a reduced fraction
of ejection (FE), characterizing a systolic dysfunction. FE was
significantly more compromised among men, regardless of
the method employed. [Cube: 50.0 (± 16.4) × 63.0 (± 17.8)
p=0.041; Teicholtz: 42.0 (± 16.1) × 55.0 (± 17.4) p=0.0420,
Mann-Whitney](Table 3).
Table 3 - Ecodopplercardiogram according to gender – Campinas - 2002-2003
Observed values
(average, standard deviation)Ecodopplercardiogram
variables Men
( N=19)
Women
( N=13)
LV systolic diameter (cm)
LV diastolic diameter (cm)
Fraction of Ejection - Cube (%)
Fraction of Ejection - Teicholtz (%)
Left atrium diameter (cm)
Thickness of the septum in diastolis (mm)
Thickness of the posterior wall (mm)
5.0 (± 1.1)* 3.9 (± 1.4)* 2.6 to 3.9
6.4 (± 0.9) 5.5 (± 1.4) 3.5 to 5.6
50.0 (± 16.4)** 63.0 (± 17.8)** 65 to 78
42.0 (± 16.1) 55.0 (± 17.4)*** 53 to 77
4.8 (± 0.8) 5.0 (± 1.4) 1.8 to 4.0
10.3 (± 0.3) 11.0 (± 0.2) 7 to 11
10.0 ( ± 0.2) 11.0 (± 0.16) 7 to 11
Normality
values
*Mann-Whitney, p = 0.0329; **Mann-Whitney, p = 0.041;***Mann-Whitney, p = 0,0420
According to the patient, the reason for HF worsening
and the consequent necessity of hospitalization was attrib-
uted to: the presence of symptoms (27.8%), stressing fac-
tors (16.4%), other associated clinical conditions (8.2%),
inadequate habits like smoking and unhealthy diet (6.6%).
Nearly half of the patients (41.0%) could not identify the
reason that led them to decompensation and the need for
hospitalization.
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Regarding the precipitating event of the current hospi-
talization, the high prevalence of symptoms was observed,
noting dyspnea 86.9%, followed by lower limb edemas
(55.7%), coughing (24.6%) and abdominal pain (16.4%).
As for the history of hospitalizations due to HF, most sub-
jects (60.7%) reported previous hospitalizations, with 64.8%
reporting from 1 to 5 previous hospitalizations. The average
number of previous hospitalizations was 2.35 (±0.75), with a
high variability in the average time between hospitalizations
(Table 4). Although the average time between hospitaliza-
tions had been lower among females than among males, this
difference was not significant in any period.
Table 4 – Distribution of the subjects who reported previous hospitalizations, according to hospitalization place and the length of time
(in days) between the re-hospitalizations– Campinas - 2002-2003.
Place
of first
hospitalization
Male
Hospital*
65,0 %
(n=20)
Average:
287,6
( ± 560,3)
Median: 60
Hospital
71,4 %
(n=17)
Average
206,3
( ± 228)
Median: 90
Hospital
66,7 %
(n=12)
Average
425,7
( ± 949,1)
Median: 37
Female
Hospital
70,6%
(n=17)
Average
151,0
( ± 213,3)
Median: 67,5
Hospital
76,9%
(n=13)
Average
104,1
( ± 89,6)
Median: 82,5
Hospital
72,7%
(n=11)
Average
79,1
( ± 47,9)
Median: 82,5
Total
(M+F)
Hospital
67,6 %
(n=37)
Average:
227,8
( ± 442,7)
Median: 60
Hospital
70,0 %
(n=30)
Average
159,8
( ± 182,7)
Median: 82,5
Hospital
69,6 %
(n=23)
Average
262,2
( ± 695,1)
Median: 60
Average time between
the 1 and 2
st nd
hospitalization (days)
Place of
the second
hospitalization
Average time between
the 2 and 3
nd rd
hospitalization (days)
Place of
the third
hospitalization
Average time between
the 3 and 4
rd th
hospitalization (days)
* Studied hospital
Regarding the characterization of the clinical monitoring
of HF, most subjects (75.4%) reported periodical monitoring,
with 30.4% of 40 patients reporting monthly monitoring, 17.4%
bi-monthly monitoring, another 17.4% every six months and
28.2% in periods over six months. As for the monitoring place,
half the patients mentioned the outpatient clinic of the uni-
versity hospital, 19.6% healthcare centers, 17.4% other ser-
vices and 10.9% hospitals in their hometown. The distribu-
tion of the subjects in relation to monitoring and compliance
with clinical follow-up are represented in Figure 1.
PERIODICAL CLINICAL
MONITORING
YES
n=46
NO
n=15
NON-COMPLIANT
N=07
REASONS FOR
NOT MONITORING
Reasons for
non-compliance
- patient does not know
that he has a heart
condition
- problems at the healthcare
center
- family problems
Reasons for compliance
- acknowledging the
severity of the disease
- acknowledging the
importance of the
treatment
- having easy access
- other
COMPLIANT
n=39
STUDIED
SUBJECTS
n=61
- difficulty of access to the
healthcare service
- bad service provided at
the healthcare facility
- family problems
- forgetfulness
Figure 1 - Distribution of the 46 subjects regarding regular monitoring and compliance with clinical follow-up – Campinas - 2002-2003
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It was observed that, out of the 46 subjects undergoing
clinical monitoring, 84.8% reported that they complied with
periodical appointments. The reason these 39 patients most
often mentioned to comply with the follow-up appointments
was acknowledging the severity of the disease (28.2%), fol-
lowed by the importance of having easy access to the
healthcare service (25.6%), acknowledgment of the impor-
tance of the treatment (20.5%) and, less frequently, commit-
ment with the medical team and the desire for a cure.
The most frequent reason for non-compliance among
the seven patients was the difficulty to access the healthcare
service related to transportation (57.1%), followed by in-
adequate service provided at the healthcare facility, family
problems and forgetfulness, in similar proportions (14.3%).
Of the 15 patients who reported not undergoing moni-
toring, 73.3% mentioned not knowing about their diagno-
sis, 20.0% reported problems with the healthcare center
that did not refer them to monitoring, being restricted to
the emergency appointments, and 6.7% reported family
problems.
As for the previous and current therapies used by the
patients, diuretics were predominant in 84.9% (45/53) and
93.4% (57/61) of the subjects, respectively. Not all patients
use the converting enzyme inhibitor (ACEI). Previous usage
is observed in less than half the subjects (60.4%, 32/53),
and increasing frequency of use during hospitalization
(71.7%; 43/60) (Table 5).
Table 5 – Previous and current drug therapy of the HF patients – Campinas - 2002-2003
Drug Therapy
Previous Currents
N % N %
ACEI* 32/53 60.4 43/61 70.5
ARAII** -- -- -- --
Diuretics 45/53 84.9 57/61 94.4
Spironolactone 16/53 30.2 29/61 47.5
Beta Blocker 4/53 7.5 8/60 13.3
Digital

23/53 43.4 20/60 33.3
Hydralazine + nitrate 16/53 30.2 19/60 31.7
Platelet anti-aggregator 13/53 24.5 20/60 33.3
Anticoagulant 9/53 17.0 17/60 28.3
Antiarrhythmic 9/53 17.0 12/60 20.0
Diazepinics 5/53 9.4 07/61 11.4
Others

23/53 43.5 51/61 83.6
+
++
* angiotensin-converting enzyme inhibitor (captopril); **angiotensin receptor antagonist II; +diuretic (hydrochlorothiazide, chlortalidone,
furosemide);  ++Beta blocker (propranolol and carvedilol); •Digital (digoxin, digitoxin and cedilanide); ??Others: anti-emetics,
hypoglycemiants, antibiotics, analgesics, antipyretic, statins, neuroleptics, nitrates, antidepressants, bronchodilators, mycophenolates,
calcium carbonates, electrolytes,  sympathomimetics, antacids and anti-inflammatory agents.
DISCUSSION
Literature(13-14) notes the influence of low socioeconomic
levels, more specifically low income(14), on the increased risk
of re-hospitalizations due to HF. In this study, most patients
were characterized by low income and low education, which
represents evidence of high risks of re-hospitalization. An-
other interesting data regards the average age of the pa-
tients, which is lower than the average described in inter-
national literature, data that was also observed in HF dec-
ompensation. In the study comparing results from HF treat-
ment among tertiary hospitals in Brazil and the United
States(15), Brazilians with HF also had lower average ages.
Although 50% of the patients were younger than 60,
only 2.6% of them were professionally active. This shows
the strong social impact of HF, which removes individuals
from the job market who are still in their productive years.
Regarding social and family support, the studied group
seems to have advantages that can be explored in nurses’
educational activity, since most of them were married, liv-
ing with a spouse and children and literature has described
that HF patients who live alone have worse QoL(16).
As for the clinical characterization, the complexity of
the syndrome is demonstrated by the high co-existence of
clinical conditions, the presence of structural heart injuries
and LV dysfunction, as well as the history of hospitaliza-
tions – average 2.35 per patient, with average intervals be-
tween five and nine months.
The associated clinical conditions of the studied patients
include SH and coronary disease, which has been associ-
ated to worse HF prognostics(6).
Regarding the signs and symptoms that led to hospital-
ization, those with the congestive form of HF decompensa-
tion are noted, with dyspnea and edema as the most preva-
lent. At hospitalization, other signs and symptoms were
registered, such as rales, hepatomegaly, ascites, noting the
prevalence of the congestive form of HF decompensation.
According to literature, HF patients who have volume over-
loads represent the largest share of patients with decom-
pensated HF(6).
In general, the patients tend to report a gradual begin-
ning of the edema or ascites, increasing symptoms of fa-
tigue or dyspnea and reduction of the basal response to
the diuretic. Although these signs are frequent, it is impor-
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tant to note that, even in the case of a substantial amount
of body fluid, as a consequence of the increased venous
capacity in these patients, a subgroup of these patients may
not present the characteristic signs of congestion. There-
fore, other evidence of HF decompensation or risk factors
for decompensation should also be investigated.
In a study about the length of each HF symptom experi-
enced by elderly adults until they decide to turn to a hospi-
tal emergency service for evaluation, the following reports
were observed: dyspnea for an average period of three days,
reduced to a 12-hour period if the symptoms were acute(17).
For edemas, weight gain, coughing and fatigue, the aver-
age was seven days. Dyspnea is perceived by the patient as
more threatening, being probably the most predominant
discomfort reported.
It is worth noting, however, that the signs and symptoms
were more frequent in this study according to the researcher’s
assessment. Considering a low likelihood of nearly all the
participants presenting worsening situations, after hospital-
ization, it seems possible that these data were underesti-
mated in the registry performed when the patient was ad-
mitted, due to the non-existence of a systematized script for
the assessment of patients with HF decompensation, which
will direct its systematic investigation and registry, recording
the most evident or reported signs. Among the symptoms,
there is fatigue, reported in 6.5% of the medical records and
by 93.4% of the patients at the moment of the interview.
A previous study notes that fatigue, especially in the
elderly, tends to be wrongly interpreted as a result of old
age, being underestimated. Another fact worth noting is
the early start of the HF decompensation signs and symp-
toms, which are treated with tolerance by the patients but
which, if acknowledged and valorized, could lead to early
intervention, avoiding hospitalization.
While literature(17) observes the need to orient the pa-
tients to monitor their HF decompensation signs and symp-
toms, the present study also verified the need for orienta-
tion, training and establishment of service standards and
registry of healthcare professionals who provide care to
these patients, since the inadequate recording of the signs
and symptoms does not allow for a global evaluation of
the subject that could subsidize their future monitoring.
Structural injuries and dysfunctions in the LV were made
evident, highlighting the reduction of FE in the group as a
whole and significantly lower among men. Studies(2,17) have
noted the importance of early detection and treatment of
ventricular dysfunction, a condition associated to heart
remodeling, whose prevention and/or early treatment with
the use of ACEI and beta-blockers has a strong impact on
QL and survival of the patients with HF. As such, the pa-
tients in this study with a preserved ventricular function
require special attention in the establishment of the thera-
peutic strategy, especially in the control of SH and underly-
ing ischemia, which was not observed given the low num-
ber of subjects using this medication before hospitalization.
Data showed the lack of regular clinical monitoring when
the subject is not hospitalized, considering that, out of 46
patients who reported periodic clinical monitoring, 39 men-
tioned having appointments regularly, considering only
their attendance to the appointments. Therefore, nearly
half of the patients did not present regular monitoring,
which is indicated as one of the causes of decompensation
and re-hospitalization(4,8).
Moreover, the place for return appointments after the
last hospitalization is noted – which, for most patients, was
the hospital (outpatient clinic or emergency service). This
situation shows that there is a need for a rational follow-up
proposal, which, based on the gravity of the patient’s con-
dition, could permit different referrals, early detection and
intervention, as well as a periodic evaluation according to
the demand of the clinical situation, thus avoiding serious
decompensations that lead to hospitalization. Similar data
related to the difficulty of clinical follow-up were also evi-
dent in a previous study involving hypertensive patients(18).
In this study, the individual and environmental factors
were identified as responsible for non-compliance with
treatment or lack of regular follow-up. Access to the health-
care service and the problems that are inherent to the ser-
vice itself, which result in inadequate treatment according
to the patient’s perception, need to be revisited. The right
to access and good service provision should be guaranteed
– and the problem should be discussed not only locally,
but it should involve broader healthcare policies, aiming
for the recognition of HF as a public healthcare problem
that requires specific action at all levels of healthcare ser-
vices. On an individual basis, educational actions should
cover the information given to patients about their condi-
tion, gravity, prognosis and the need for regular monitor-
ing, as well as the importance of strategies aimed at over-
coming individual barriers for treatment.
The frequency of ACEI and beta-blocker use was infe-
rior to literature recommendations. National and interna-
tional studies(15,4) have evidenced the under-utilization of
ACEI. Therefore, almost ten years after the indication of
the use of ACEI, it can be verified that many patients still
lack the benefits of using the two only drugs that, until now,
are proven to change the course of HF evolution.
FINAL CONSIDERATIONS
As a final reflection, it should be noted that the find-
ings in this study need to be interpreted carefully, since they
were obtained from a small sample size, not representa-
tive of a 12-month period. However, the data show that
the hospitalized patients presented a large amount of fac-
tors that have been associated to HF decompensation and
repeated hospitalizations. This is a group that presents clini-
cal complexity, with irregular clinical follow-up and sub-uti-
lization of the recommended drug therapy, indicating the
need to design and implement interventions that will al-
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low for better follow-up and control of HF patients. Broad-
ening the study, with investigation of hospitalizations over
the year, as well as the follow-up of patients after hospital
discharge, can provide even more support to guide the
design of educational clinical interventions.
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